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NEUTROPHIL-TUMOR CELL PHAGOCYTOSIS (CANNIBALISM) 
IN HUMAN TUMORS: AN UPDATE AND LITERATURE REVIEW
R.A. Caruso*, F. Fedele, G. Finocchiaro, G. Arena, A. Venuti
Department of Human Pathology, University of Messina, Messina, Italy
The recognition and removal of apoptotic cells by tissue macrophages and nonprofessional phagocytes, in a process called effero-
cytosis, is critical for development, tissue homeostasis and resolution of inflammation. Apoptotic bodies arising in tumor tissue are 
ingested by viable neoplastic cells and by resident macrophages. We described tumor cell phagocytosis of apoptotic neutrophils 
in human gastric carcinomas. This phenomenon is analogous to neutrophil efferocytosis performed by macrophages and by non-
professional phagocytes during inflammatory reaction but is distinct by other types of cell-in-cell phenomena including emperipole-
sis and entosis both cytologically and biologically. In this review, we discussed them in their ultrastructural morphology, physiolo-
gical roles, and clinicopathologic implications. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
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INTRODUCTION
The expression “apoptosis” has been coined 
by Kerr et al. [1] to describe the phenomenon 
as a mode of cell death morphologically separate from 
coagulative necrosis. Apoptosis is characterized by the 
sequence of nuclear shrinkage (pyknosis), chromatin 
margination, nuclear fragmentation (karyorhexis), and 
engulfment by neighboring cells. All of these changes 
occur before plasma membrane integrity is lost [2]. 
Electron microscopy permits the visualization of fine 
ultrastructural modifications that accompany cell 
death, including gaps in the plasma and/or in the mito-
chondrial outer membrane [3], mitochondrial swelling 
[4], and the first phases of chromatin condensation 
(which only later become visible by light microscopy) 
[5]. Phagocytosis of apoptotic cells, also known as ef-
ferocytosis, is performed by both professional phago-
cytes (such as macrophages and dendritic cells) and 
by nonprofessional “neighboring” phagocytes (such 
as epithelial cells, endothelial cells, and fibroblasts) 
[6]. For example, viable epithelial cells recognize and 
engulf their apoptotic neighbours in normal epithelia 
in vivo [7], while the glomerular mesangial cell ingests 
both leucocytes and adjacent apoptotic glomerular 
cells during the resolution of renal inflammation [8]. 
More recently, mouse mammary gland epithelial cells 
have been reported to ingest apoptotic alveolar cells 
during the process of mammary gland involution [9].
NEUTROPHIL EFFEROCYTOSIS
Neutrophils are classified as professional phago-
cytes, and are important in resolution and clear-
ance of pathogens. They are known to phagocytose 
pathogens (including yeast and bacteria) as well 
as potentially hazardous substances, being a first 
line defence. Neutrophils are inherently short-lived 
cells with a half life of only ~ 6–10 h in the circulation 
and rapidly undergo spontaneous apoptosis [10]. 
Apoptotic inflammatory neutrophils are phagocytosed 
primarily by macrophages, provided these cells are 
present in adequate numbers. However, macrophages 
are rare at sites of acute inflammation, whereas the 
number of neutrophils can be extremely high [11]. 
Therefore, nonprofessional phagocytes and/or viable 
neutrophils can participate in the clearance of apop-
totic neutrophils [11].
There is surprisingly little data about efferocytosis 
of neutrophils by epithelial cells. Sexton et al. [12] have 
demonstrated that human epithelial cells from differ-
ent regions of the lung recognize and ingest apoptotic 
eosinophils but not apoptotic neutrophils. Thus, hu-
man airway epithelial cells might be active participants 
in the removal of apoptotic eosinophils and therefore 
play an important role in the resolution of eosinophilic 
inflammation in the asthmatic lung [12]. Sexton et al. 
[12] suggest that epithelial cells at different organ 
sites retain a selective ability to recognize and engulf 
only one of the two apoptotic granulocytes. The rea-
sons for such differences are unclear but may reflect 
the employment of subsets of cooperating phago-
cytic receptors for particular apoptotic cell types [12]. 
We are currently examining a large number of chronic 
active H. pylori gastritis for the presence of apoptotic 
neutrophils within foveolar epithelium. Transmission 
electron micrographs revealed apoptotic neutrophils 
within spacious phagosomes of foveolar cells. These 
findings are compatible with late phase of neutrophil 
efferocytosis by foveolar cells and suggest their anti-
inflammatory role in the removal of apoptotic neutro-
phils during acute foveolitis. The clinical implications 
of our findings in these patients are under study.
“PHYSIOLOGICAL” AND “PATHOLOGICAL” 
INFLAMMATION
Because uncontrolled release of toxic substances 
from dead neutrophils can propagate the inflammatory 
response leading to tissue destruction, recognition 
of dying inflammatory neutrophils has a critical func-
tion for the resolution of the inflammatory response 
[13]. It leads not only to the removal of the inflamma-
tory cells themselves, along with anything they have in-
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gested, but also to the generation of anti-inflammatory 
mediators that shut down the ongoing inflammation 
[14]. This condition may be defined “physiological” 
inflammation [14]. However, if macrophages and/
or nonprofessional phagocytes fail to clear the apop-
totic neutrophils, apoptotic neutrophils are left in the 
tissue and undergo secondary necrosis: a process 
characterized by uncontrolled leakage of the dying cell 
contents resulting in a propagated inflammatory re-
sponse [13]. In this condition of “pathological” inflam-
mation activated immune cells, primarily represented 
by neutrophils, macrophages, and cytotoxic T cells, 
play the role of aggressors that attack and destroy 
nearby cells, either directly through physical contact 
or indirectly through the release of soluble factors such 
as reactive oxygen and nitrogen metabolites, cytotoxic 
proteins, lytic enzymes, or cytokines [14, 15]. There-
fore, neutrophils are potentially very cytotoxic, mainly 
when they lyse [16]. The harm associated to the par-
ticipation of neutrophils in inflammatory situations can 
be considerable, as neutrophils are usually recruited 
in high number to inflammatory/infectious sites [16]. 
These features of neutrophil participation in inflam-
matory situations associated to infection or tissue 
injury make the neutrophil a dangerous cell that must 
be tightly controlled.
TRANSEPITHELIAL NEUTROPHIL 
MIGRATION
Common to the rapidly growing, multifaceted 
literature on mechanisms of resolution of inflamma-
tory disease processes is the centrality of leukocyte 
apoptosis followed by phagocytosis of the apoptotic 
leukocyte [13, 17]. Apoptosis mechanisms are con-
sistently emphasized whereas it appears that a role 
of transepithelial cell migration may have been over-
looked. Contributing to the limited attention, another 
prevailing dogma has taught that the transepithelial 
movement of leucocytes is an injury-evoking, patho-
genic component of mucosal inflammatory diseases 
[18]. The transepithelial leucocyte egression is re-
quired for surveillance, sentinel and defence duties 
to be carried out in part on the mucosal surface and, 
likely, also in the lumen [18]. Migration of neutrophils 
across the mucosa may be critical to a successful 
combating of mucosal infections [19]. Hence, it is re-
assuring that the transepithelial exit of granulocytes 
can occur without compromising the integrity of the 
mucosal epithelial barrier [20, 21]. Epithelial restitution 
after shedding-like epithelial damage, which does not 
injure the basement membrane, can be a very rapid 
process in vivo [22]. However, for a well-functioning 
disease-resolving process, transepithelial elimination 
of leucocytes would have to occur without inflicting any 
injury at all [22]. Occurrence of inflammatory cells such 
as eosinophils, neutrophils, lymphocytes, dendritic 
cells and mast cells in the lumen of mucosal lined hol-
low organs has demonstrated that transepithelial elimi-
nation of such cells is operational at disease resolution 
[18]. Many clinical observations and pharmacological 
in vivo evidence, accumulating in recent decades, are 
compellingly supportive [18]. Hence, transepithelial 
migration emerges as an additional mode of ridding 
diseased mucosal tissues of inflammatory cells. 
However, a resolving role of moving leucocytes into 
the lumen of hollow organs has limitations [23]. For 
example, a distinction must be made between egres-
sion of infiltrated leucocytes across mucosal epithelia 
where a swift further elimination of the lumen cells can 
be expected to occur (nasal, tracheobronchial, gut and 
bladder mucosae) and the bronchiolar-alveolar epi-
thelial linings where there is a risk of harmful accumula-
tion of lumen cells [22]. Neutrophil persistence in the 
airways can occur through a number of mechanisms 
such as impaired apoptosis, efferocytosis and mucus 
hypersecretion, all of which are impaired in airways dis-
ease [22]. Impairment of neutrophil clearance results 
in a reduced ability to respond to bacterial infection 
[22]. Persistent activation of airway neutrophils may 
result in the persistent activation of the innate immune 
system resulting in further airway insult [22].
EMPERIPOLESIS AND ENTOSIS
Humble et al. [24] coined the term “emperipole-
sis” in 1950s to define the heterogeneous cell-in-cell 
phenomena when they studied biological interaction 
of lymphocytes with other cells. Emperipolesis has 
since been found to be commonly enacted by lym-
phocytes in physiological and pathophysiological set-
tings [25]. Recently, Overholtzer et al. [26] observed 
a homogeneous cell-in-cell phenomenon and named 
it as “entosis”, an intercellular process that exhibits 
remarkable similarity to emperipolesis. Entosis has 
been observed in many cell lines at varying frequen-
cies, including breast epithelial cells, breast carcinoma 
cells, and human embryonic kidney cells [27]. Inter-
nalized cells initially appear healthy and viable; some 
even divide while inside of the host [28]. Over a period 
of 20 hours, some internalized cells are able to escape, 
but most cells die through a specialized form of cell 
death that lacks hallmarks of apoptosis, as dying cells 
are negative for cleaved caspase-3 and do not exhibit 
condensed or fragmented nuclei [26, 29].
PHAGOCYTOSIS: A SHARED BEHAVIOR 
OF M2 MACROPHAGES AND TUMOR 
CELLS
Tumor cell cannibalism was described as the abi-
lity of tumor cells to cannibalize their siblings as well 
as cells from the immune system [30, 31]. In cytologi-
cal or histological samples of human tumors it is a com-
mon finding to detect cells with one or more vacuoles, 
possibly containing cells under degradation, that 
push the nucleus to the periphery giving it the shape 
of a crescent moon [32]. The process of entosis is dif-
ferent from cannibalism in that entosis is a live cell inva-
sion while cannibalism has no selectivity for dead cells 
or live cells [26–28]. Furthermore, entosis is a homo-
geneous cell-in-cell phenomenon while cannibalism 
can be either homogeneous or heterogeneous cell-
in-cell structures [33, 34]. While phagocytic behaviors 
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have been reported for most forms of human cancer, 
not all cancer cells within a tumor are phagocytic. For 
most of the tumor described, phagocytic/cannibalistic 
behavior was restricted primarily to those cells that are 
highly invasive and metastatic [35–37].
Phagocytosis is a specialized behavior of M2 mac-
rophages and other professional phagocytes. M2 mac-
rophages also express high levels of lysosomal-
enriched cathepsins, which facilitate the digestion 
of proteins ingested following phagocytosis [38, 39]. 
Interestingly, lysosomal cathepsins D and B are viewed 
as prognostic factors in cancer patients [40, 41]. A high 
content of these enzymes in tumors of the head and 
neck, breast, brain, colon, or endometrium was con-
sidered a sign for high malignancy, high metastasis, 
and overall poor prognosis [42]. These data suggest 
that numerous human cancers express multiple prop-
erties of M2 macrophages including phagocytosis and 
protein expression.
TUMOR CELL PHAGOCYTOSIS/
CANNIBALISM OF NEUTROPHILS
The phenomenon of neutrophil-tumor cell em-
peripolesis or phagocytosis (cannibalism) has been 
documented by the light microscopy in pleomorphic 
(giant) cell carcinomas of the lung, gall bladder, pan-
creas, and intestine [43–47]. Pleomorphic (giant) cell 
carcinoma is defined as a tumor lacking any identifi-
able glandular, squamous or other differentiation [48]. 
The characteristic histologic findings include marked 
pleomorphism, lack of cohesiveness of tumor cells, 
aggregates or sheets of mononucleated and multi-
nucleated giant cells, and extensive necrosis [48]. One 
peculiar finding in invasive micropapillary carcinoma 
of ampullo-pancreatobiliary region noted by Khayyata 
et al. [49] is the presence of tumor-infiltrating neutro-
phils. Neutrophils were abundant and could be identi-
fied both within the carcinoma cells (“cannibalism”) 
as well as in the stroma adjacent to the tumor cells 
[49]. Furthermore, the neutrophils showed striking 
tumoral-centric distribution, decreasing in num-
bers away from the tumor cells. Thus, phenomenon 
of neutrophil-tumor cell emperipolesis or phagocytosis 
(cannibalism) has been reported in pleomorphic giant 
cell carcinoma and in micropapillary carcinomas: two 
histologic types characterized by a poor prognosis.
In order to study the phenomenon of neutrophil-tu-
mor cell emperipolesis or phagocytosis (cannibalism) 
in gastric tumor, we reviewed and analyzed the ultra-
structural findings observed in 9 cases of advanced 
gastric carcinomas [30]. An intraepithelial localization 
of neutrophils was seen in 2 out of 9 cases (Fig. 1). 
They showed the characteristic equipment of discrete 
primary and secondary granules, glycogen and lipid 
bodies. Other neutrophils were present within vacuoles 
of adenocarcinoma cells and showed various phases 
of apoptotic changes. Ultrastructural signs of early 
apoptosis included nuclear chromatin separation into 
dense and electron lucent areas, rounded nuclear 
profiles, preservation of cytoplasmic granules, and 
maintenance of cell membrane integrity of neutrophils 
(Fig. 2). Late apoptotic morphology was characterized 
by cell shrinkage, tightly packed cytoplasmic granules, 
and uniform collapsed nucleus (Fig. 3) [30]. 
Fig. 1. Intestinal-type gastric adenocarcinoma with intraepithe-
lial neutrophil localization (arrow) × 4 000
Fig. 2. Intestinal-type gastric adenocarcinoma. An intraepithelial 
neutrophil shows early apoptotic changes, including nuclear 
chromatin separation into dense and electron-lucent areas (ar-
rows), preservation of cytoplasmic granules, and maintenance 
of cell membrane integrity. × 6 000
Fig. 3. Adenocarcinoma showing intraepithelial neutrophil with 
late apoptotic changes such as cell shrinkage, tightly packet cyto-
plasmic granules, and uniform collapsed nucleus (arrow). × 6 000
Secondary degeneration of apoptotic neutrophils 
within the phagocytic vacuoles of tumor cells in-
cluded cellular swelling, electron-lucent cytoplasm, 
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vacuolization and indiscernible cell membrane (Fig. 4). 
Viable neutrophils, cell debris and apoptotic neutro-
phils were also observed within the lumina of gastric 
tumor (Fig. 4 and 5). In summary, the ultrastructural 
study shows the presence of apoptotic neutrophils 
within cytoplasmic vacuoles of adenocarcinoma cells. 
Therefore, the phagocytic nature (cannibalism) of this 
interaction was demonstrated, and the possibility 
of emperipolesis/entosis was excluded.
Fig. 4. Neutrophil-tumor cell phagocytosis. Late apoptotic 
neutrophil is contained within spacious phagosome (arrow). 
Note various stages of secondary degeneration in phagocytosed 
neutrophil including swollen cytoplasm, loss of glycogen gran-
ules, vacuolization, and indiscernible cell membrane. × 10 000
Fig. 5. Adenocarcinoma containing an apoptotic neutrophil 
(arrow) and cell debris. × 10 000
MALIGNANT TUMOR CELLS FEED 
ON INGESTED CELLS
Recently, Lugini et al. [35] investigated the oc-
currence, the in vivo relevance, and the underlying 
mecha nisms of cannibalism in human melanoma. 
As first evidence, they observed that tumor cannibal-
ism was clearly detectable in vivo in metastatic le-
sions of melanoma and often involved T cells, which 
could be found in a degraded state within tumor cells. 
Then, in vitro experiments confirmed that cannibal-
ism of T cells was a property of metastatic melanoma 
cells but not of primary melanoma cells. In particu-
lar, morphologic analyses, including time-lapse 
cinematography and electron microscopy, revealed 
a sequence of events, in which metastatic melanoma 
cells were able to engulf and digest live autologous 
melanoma-specific CD8+ T cells [35]. Importantly, this 
cannibalistic activity significantly increased metastatic 
melanoma cell survival, particularly under starvation 
condition, supporting the evidence that tumor cells 
may use the eating of live lymphocytes as a way to 
“feed” in condition of low nutrient supply [35]. The 
mechanism underlying cannibalism involved a com-
plex framework, including lysosomal protease cathep-
sin B activity, caveolae formation, and ezrin cytoske-
leton integrity and function. In conclusion, Lugini et al. 
[35] suggest that cannibalism may represent a sort 
of “feeding” activity aimed at sustaining survival and 
progression of malignant tumor cells in an unfavorable 
microenvironment.
HORIZONTAL TRANSFER OF DNA 
BY UPTAKE OF APOPTOTIC BODIES
It has been generally considered that DNA from 
dying cells is degraded after apoptosis and, thus, in-
activated. However, recent studies have demonstrated 
that horizontal DNA transfer between mammalian cells 
can occur through the uptake of apoptotic bodies, 
where genes from the apoptotic cells were transferred 
to neighbouring cells phagocytosing the apoptotic 
bodies [50–54]. The regulation of this process is poorly 
understood. p53, via the activation of p21, blocks 
normal cells from replicating transferred DNA from 
engulfed apoptotic bodies [54, 55]. This may be one 
protection level against the propagation of potentially 
pathological DNA [54]. It was shown that the ability 
of cells as recipient of horizontally transferred DNA 
was enhanced by deficiency of p53 or p21 [54]. It has 
been suggested that horizontal transfer of DNA from 
apoptotic bodies could be one explanation to the 
chromosomal instability observed in cancer cells [54]. 
CONCLUSIONS
We have attempted to consider the importance 
of neutrophil efferocytosis within the context of the 
appropriate immune response to invading pathogens 
and the inappropriate or excessive inflammation 
in inflammatory disease. We have mentioned that hu-
man gastric adenocarcinoma cells may phagocytose 
apoptotic neutrophils: a phenomenon similar to that 
described in efferocytosis of neutrophils during inflam-
matory reaction but distinct by other types of cell-in-
cell phenomena including emperipolesis and entosis 
both cytologically and biologically. We have high-
lighted that tumors may take advantage of neutrophil 
phagocytosis for survival and immune evasion. Where 
horizontal DNA transfer from apoptotic cells to neo-
plastic cells, phagocytosing the apoptotic bodies, 
determine their chromosomal instability, will require 
further exploration.
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